Cluster composition

Functions

Category	Name	IntersectionWithQuery	PValue	GenesInTerm	GenesInQuery	GenesInTermInQuery	ID
Domain	-	DCAF8 COPB2 WDR27 CFAP43 SEC31B ARHGEF17 SEMA4G HIRA PLAA CDC40 NUP37 IFT80 LRBA MAPKBP1 SPAG16 WDR17 WDR62 FBXW7	3.92e-09	333	180	18	2.130.10.10
Domain	WD40/YVTN_repeat-like_dom	DCAF8 COPB2 WDR27 CFAP43 SEC31B ARHGEF17 SEMA4G HIRA PLAA CDC40 NUP37 IFT80 LRBA MAPKBP1 SPAG16 WDR17 WDR62 FBXW7	4.31e-09	335	180	18	IPR015943
Domain	WD40_repeat_dom	DCAF8 COPB2 WDR27 CFAP43 SEC31B ARHGEF17 HIRA PLAA CDC40 NUP37 IFT80 LRBA MAPKBP1 SPAG16 WDR17 WDR62 FBXW7	4.62e-09	297	180	17	IPR017986
Domain	WD40	DCAF8 COPB2 WDR27 CFAP43 SEC31B HIRA PLAA CDC40 NUP37 IFT80 LRBA MAPKBP1 SPAG16 WDR17 WDR62 FBXW7	7.38e-09	268	180	16	SM00320
Domain	WD40_repeat	DCAF8 COPB2 WDR27 CFAP43 SEC31B HIRA PLAA CDC40 NUP37 IFT80 LRBA MAPKBP1 SPAG16 WDR17 WDR62 FBXW7	9.11e-09	272	180	16	IPR001680
Domain	WD_REPEATS_1	DCAF8 COPB2 WDR27 CFAP43 SEC31B HIRA PLAA CDC40 NUP37 IFT80 LRBA MAPKBP1 SPAG16 WDR17 WDR62 FBXW7	1.24e-08	278	180	16	PS00678
Domain	WD_REPEATS_2	DCAF8 COPB2 WDR27 CFAP43 SEC31B HIRA PLAA CDC40 NUP37 IFT80 LRBA MAPKBP1 SPAG16 WDR17 WDR62 FBXW7	1.31e-08	279	180	16	PS50082
Domain	WD_REPEATS_REGION	DCAF8 COPB2 WDR27 CFAP43 SEC31B HIRA PLAA CDC40 NUP37 IFT80 LRBA MAPKBP1 SPAG16 WDR17 WDR62 FBXW7	1.31e-08	279	180	16	PS50294
Domain	WD40	DCAF8 COPB2 WDR27 SEC31B HIRA PLAA CDC40 NUP37 IFT80 LRBA MAPKBP1 SPAG16 WDR17 WDR62 FBXW7	3.32e-08	259	180	15	PF00400
Domain	-	SCRT2 ZNF266 ZBTB48 ZFP57 ZNF225 ZNF112 KLF4 REPIN1 ZNF331 ZNF7 ZNF17 PRDM9 ZNF26 ZNF550 GLI1 ZNF358 ZNF620 ZNF749 ZNF841 ZNF443	9.27e-06	679	180	20	3.30.160.60
Domain	zf-C2H2_6	SCRT2 ZNF266 ZBTB48 ZNF225 ZNF331 ZNF17 PRDM9 ZNF26 ZNF358 ZNF620 ZNF749 ZNF841 ZNF443	1.16e-05	314	180	13	PF13912
Domain	zf-C2H2	SCRT2 ZNF266 ZBTB48 ZFP57 ZNF225 ZNF112 KLF4 REPIN1 ZNF331 ZNF7 ZNF17 PRDM9 ZNF26 ZNF550 GLI1 ZNF358 ZNF620 ZNF749 ZNF841 ZNF443	1.25e-05	693	180	20	PF00096
Domain	Znf_C2H2/integrase_DNA-bd	SCRT2 ZNF266 ZBTB48 ZFP57 ZNF225 ZNF112 KLF4 REPIN1 ZNF331 ZNF7 ZNF17 PRDM9 ZNF26 ZNF550 GLI1 ZNF358 ZNF620 ZNF749 ZNF841 ZNF443	1.27e-05	694	180	20	IPR013087
Domain	KRAB	ZNF266 ZFP57 ZNF225 ZNF112 ZNF331 ZNF7 ZNF17 PRDM9 ZNF26 ZNF550 ZNF620 ZNF747 ZNF749 ZNF443	1.43e-05	369	180	14	SM00349
Domain	KRAB	ZNF266 ZFP57 ZNF225 ZNF112 ZNF331 ZNF7 ZNF17 PRDM9 ZNF26 ZNF550 ZNF620 ZNF747 ZNF749 ZNF443	1.47e-05	370	180	14	IPR001909
Domain	KRAB	ZNF266 ZFP57 ZNF225 ZNF112 ZNF331 ZNF7 ZNF17 ZNF26 ZNF550 ZNF620 ZNF747 ZNF749 ZNF443	4.58e-05	358	180	13	PS50805
Domain	KRAB	ZFP57 ZNF225 ZNF112 ZNF331 ZNF7 ZNF17 PRDM9 ZNF26 ZNF550 ZNF620 ZNF747 ZNF749 ZNF443	4.58e-05	358	180	13	PF01352
Domain	ZINC_FINGER_C2H2_2	SCRT2 ZNF266 ZBTB48 ZFP57 ZNF225 ZNF112 KLF4 REPIN1 ZNF331 ZNF7 ZNF17 PRDM9 ZNF26 ZNF550 GLI1 ZNF358 ZNF620 ZNF749 ZNF841 ZNF443	6.06e-05	775	180	20	PS50157
Domain	ZINC_FINGER_C2H2_1	SCRT2 ZNF266 ZBTB48 ZFP57 ZNF225 ZNF112 KLF4 REPIN1 ZNF331 ZNF7 ZNF17 PRDM9 ZNF26 ZNF550 GLI1 ZNF358 ZNF620 ZNF749 ZNF841 ZNF443	6.28e-05	777	180	20	PS00028
Domain	Znf_C2H2-like	SCRT2 ZNF266 ZBTB48 ZFP57 ZNF225 ZNF112 KLF4 REPIN1 ZNF331 ZNF7 ZNF17 PRDM9 ZNF26 ZNF550 GLI1 ZNF358 ZNF620 ZNF749 ZNF841 ZNF443	8.74e-05	796	180	20	IPR015880
Domain	Znf_C2H2	SCRT2 ZNF266 ZBTB48 ZFP57 ZNF225 ZNF112 KLF4 REPIN1 ZNF331 ZNF7 ZNF17 PRDM9 ZNF26 ZNF550 GLI1 ZNF358 ZNF620 ZNF749 ZNF841 ZNF443	1.02e-04	805	180	20	IPR007087
Domain	ZnF_C2H2	SCRT2 ZNF266 ZBTB48 ZFP57 ZNF225 ZNF112 KLF4 REPIN1 ZNF331 ZNF7 ZNF17 PRDM9 ZNF26 ZNF550 GLI1 ZNF358 ZNF620 ZNF749 ZNF841 ZNF443	1.07e-04	808	180	20	SM00355
Domain	ABC_membrane_2	ABCD3 ABCD4	5.47e-04	4	180	2	PF06472
Domain	Anaphylatoxin_comp_syst	C4A C4B	9.06e-04	5	180	2	IPR018081
Domain	Anaphylatoxn_comp_syst_dom	C4A C4B	9.06e-04	5	180	2	IPR001840
Domain	WD40_repeat_CS	SEC31B HIRA CDC40 NUP37 SPAG16 WDR17 FBXW7	1.07e-03	164	180	7	IPR019775
Domain	Adcy_conserved_dom	ADCY7 ADCY8	1.35e-03	6	180	2	IPR009398
Domain	DUF1053	ADCY7 ADCY8	1.35e-03	6	180	2	PF06327
Domain	EFhand_Ca_insen	ACTN1 ACTN2	1.35e-03	6	180	2	PF08726
Domain	EF-hand_Ca_insen	ACTN1 ACTN2	1.35e-03	6	180	2	IPR014837
Domain	Spectrin	KALRN ACTN1 ACTN2	1.35e-03	23	180	3	PF00435
Pubmed	A dual-activity topoisomerase complex regulates mRNA translation and turnover.	TANC2 DGCR2 SPHK2 CRYBG2 KALRN MYCBP2 TMC6 INTS1 OBSCN TRMT11 CFAP43 MED13L KLF4 REPIN1 ADCY7 TBC1D9 KCNH3 HIRA DIP2A LATS2 PSME4 SUGP2 MTMR14 ZNRF3 GLI1 KCNK5 PCNX1 ZFYVE26 TANC1 POFUT1 SLC45A1 LRBA MAPKBP1	1.35e-15	1105	188	33	35748872
Pubmed	Transmission of antibody-induced arthritis is independent of complement component 4 (C4) and the complement receptors 1 and 2 (CD21/35).	CR2 C4A C4B	1.55e-07	3	188	3	11857338
Pubmed	Complement C4 inhibits systemic autoimmunity through a mechanism independent of complement receptors CR1 and CR2.	CR2 C4A C4B	6.19e-07	4	188	3	11067882
Pubmed	Antigen localization within the splenic marginal zone restores humoral immune response and IgG class switch in complement C4-deficient mice.	CR2 C4A C4B	6.19e-07	4	188	3	15477230
Pubmed	Role of complement receptors 1 and 2 (CD35 and CD21), C3, C4, and C5 in survival by mice of Staphylococcus aureus bacteremia.	CR2 C4A C4B	1.54e-06	5	188	3	15192652
Pubmed	Myofibroblast YAP/TAZ activation is a key step in organ fibrogenesis.	LATS1 LATS2 TAFAZZIN	1.54e-06	5	188	3	35191398
Pubmed	Protective T cell-independent antiviral antibody responses are dependent on complement.	CR2 C4A C4B	1.54e-06	5	188	3	10523614
Pubmed	Stromal complement receptor CD21/35 facilitates lymphoid prion colonization and pathogenesis.	CR2 C4A C4B	1.54e-06	5	188	3	17947689
Pubmed	MECP2 directly interacts with RNA polymerase II to modulate transcription in human neurons.	CAD MAP1B KALRN MYCBP2 COPB2 INTS1 MRPS16 PRPF6 PLD3 USP9Y THOC2 HIRA LIPA KIDINS220 CDC40 SUGP2 DROSHA KCTD10 ABCD3 HCRTR1	1.91e-06	1082	188	20	38697112
Pubmed	CD21/35 promotes protective immunity to Streptococcus pneumoniae through a complement-independent but CD19-dependent pathway that regulates PD-1 expression.	CR2 C4A C4B	3.07e-06	6	188	3	19710450
Pubmed	The functional interactome landscape of the human histone deacetylase family.	CAD HDAC5 STAG1 MYCBP2 USP9X PRPF6 HEATR1 ADH5 PLAA TRMT61A	4.37e-06	289	188	10	23752268
Pubmed	YAP/TAZ Activation Drives Uveal Melanoma Initiation and Progression.	LATS1 LATS2 TAFAZZIN	5.35e-06	7	188	3	31801083
Pubmed	YAP1/TAZ drives ependymoma-like tumour formation in mice.	LATS1 LATS2 TAFAZZIN	5.35e-06	7	188	3	32404936
Pubmed	Divergent immunoglobulin g subclass activity through selective Fc receptor binding.	CR2 C4A C4B	8.53e-06	8	188	3	16322460
Pubmed	KCTD13-mediated ubiquitination and degradation of GluN1 regulates excitatory synaptic transmission and seizure susceptibility.	TANC2 CAD MAP1B KALRN USP9X COPB2 ACTN1 ACTN2 PLD3 ARHGEF17 JMY SLC12A5 DIP2A KIDINS220 SUGP2 KCTD10 ABCD3 C4A C4B TANC1 SLC25A23 SNTA1	1.09e-05	1431	188	22	37142655
Pubmed	SDCBP promotes pancreatic cancer progression by preventing YAP1 from β-TrCP-mediated proteasomal degradation.	LATS1 LATS2 FBXW7	1.27e-05	9	188	3	36828627
Pubmed	Functional proteomics establishes the interaction of SIRT7 with chromatin remodeling complexes and expands its role in regulation of RNA polymerase I transcription.	CAD MAP1B MYCBP2 USP9X DDX52 COPB2 INTS1 PRPF6 HEATR1 ACTN1 THOC2 SUGP2 LTF ASCC3	1.42e-05	653	188	14	22586326
Pubmed	Copy number analysis of complement C4A, C4B and C4A silencing mutation by real-time quantitative polymerase chain reaction.	C4A C4B	2.91e-05	2	188	2	22737222
Pubmed	Deficiency of C4 from donor or recipient mouse fails to prevent renal allograft rejection.	C4A C4B	2.91e-05	2	188	2	16565498
Pubmed	Complete deficiencies of complement C4A and C4B including 2-bp insertion in codon 1213 are genetic risk factors of systemic lupus erythematosus in Thai populations.	C4A C4B	2.91e-05	2	188	2	15998580
Pubmed	High-throughput analysis of the C4 polymorphism by a combination of MLPA and isotype-specific ELISA's.	C4A C4B	2.91e-05	2	188	2	19062096
Pubmed	Activation of innate and humoral immunity in the peripheral nervous system of ALS transgenic mice.	C4A C4B	2.91e-05	2	188	2	19933335
Pubmed	Structural basis for the C4d.1/C4d.2 serologic allotypes of murine complement component C4.	C4A C4B	2.91e-05	2	188	2	2459207
Pubmed	Antigen-induced B cell apoptosis is independent of complement C4.	C4A C4B	2.91e-05	2	188	2	17645767
Pubmed	Anti-DNA autoreactivity in C4-deficient mice.	C4A C4B	2.91e-05	2	188	2	12207352
Pubmed	Mutation analysis of large tumor suppressor genes LATS1 and LATS2 supports a tumor suppressor role in human cancer.	LATS1 LATS2	2.91e-05	2	188	2	25482410
Pubmed	Lats1/2-Mediated Alteration of Hippo Signaling Pathway Regulates the Fate of Bone Marrow-Derived Mesenchymal Stem Cells.	LATS1 LATS2	2.91e-05	2	188	2	30671453
Pubmed	Complement C4A and C4B Gene Copy Number Study in Alzheimer's Disease Patients.	C4A C4B	2.91e-05	2	188	2	27758680
Pubmed	Genetically determined partial complement C4 deficiency states are not independent risk factors for SLE in UK and Spanish populations.	C4A C4B	2.91e-05	2	188	2	22387014
Pubmed	Complement C4 maintains peripheral B-cell tolerance in a myeloid cell dependent manner.	C4A C4B	2.91e-05	2	188	2	23749435
Pubmed	Copy number variations of complement component C4 are associated with Behçet's disease but not with ankylosing spondylitis associated with acute anterior uveitis.	C4A C4B	2.91e-05	2	188	2	23918728
Pubmed	Molecular genetics of androgen-dependent and -independent expression of mouse sex-limited protein.	C4A C4B	2.91e-05	2	188	2	3037333
Pubmed	Thioredoxin-interacting protein mediates high glucose-induced reactive oxygen species generation by mitochondria and the NADPH oxidase, Nox4, in mesangial cells.	NOX4 TXNIP	2.91e-05	2	188	2	23329835
Pubmed	Evidence of a role for C4 in modulating interstitial inflammation in experimental glomerulonephritis.	C4A C4B	2.91e-05	2	188	2	11726230
Pubmed	Quantitative variations in the expression of the mouse serum antigen Ss and its sex-limited allotype Slp.	C4A C4B	2.91e-05	2	188	2	4216347
Pubmed	Sequence determination of the thiolester site of the fourth component of human complement.	C4A C4B	2.91e-05	2	188	2	6950384
Pubmed	Visual demonstration of the organization of the human complement C4 and 21-hydroxylase genes by high-resolution fluorescence in situ hybridization.	C4A C4B	2.91e-05	2	188	2	8660986
Pubmed	Tissue-specific RNA processing for the complement C4 gene transcript in the H-2k mouse strain.	C4A C4B	2.91e-05	2	188	2	8428773
Pubmed	A single copy of large tumor suppressor 1 or large tumor suppressor 2 is sufficient for normal hematopoiesis.	LATS1 LATS2	2.91e-05	2	188	2	32826458
Pubmed	AICAR Antiproliferative Properties Involve the AMPK-Independent Activation of the Tumor Suppressors LATS 1 and 2.	LATS1 LATS2	2.91e-05	2	188	2	29730476
Pubmed	Complement C4 deficiency--a plausible risk factor for non-tuberculous mycobacteria (NTM) infection in apparently immunocompetent patients.	C4A C4B	2.91e-05	2	188	2	24638111
Pubmed	Transcriptional repression of C4 complement by hepatitis C virus proteins.	C4A C4B	2.91e-05	2	188	2	21345967
Pubmed	Restriction fragment analysis of H-2 recombinant mouse strains with crossovers between E alpha and C4 genes.	C4A C4B	2.91e-05	2	188	2	2572548
Pubmed	The complement component C4 of mammals.	C4A C4B	2.91e-05	2	188	2	2302180
Pubmed	N-terminal truncation of Lats1 causes abnormal cell growth control and chromosomal instability.	LATS1 LATS2	2.91e-05	2	188	2	23230145
Pubmed	Gene CNVs and protein levels of complement C4A and C4B as novel biomarkers for partial disease remissions in new-onset type 1 diabetes patients.	C4A C4B	2.91e-05	2	188	2	22151770
Pubmed	C4d-positive chronic rejection: a frequent entity with a poor outcome.	C4A C4B	2.91e-05	2	188	2	18091514
Pubmed	Comprehensive approach to study complement C4 in systemic lupus erythematosus: Gene polymorphisms, protein levels and functional activity.	C4A C4B	2.91e-05	2	188	2	29080553
Pubmed	Genes for murine fourth complement component (C4) and sex-limited protein (Slp) identified by hybridization to C4- and Slp-specific cDNA.	C4A C4B	2.91e-05	2	188	2	6589636
Pubmed	Ubiquitin-specific protease activity of USP9Y, a male infertility gene on the Y chromosome.	USP9X USP9Y	2.91e-05	2	188	2	12895410
Pubmed	C4 Deficiency is a predisposing factor for Streptococcus pneumoniae-induced autoantibody production.	C4A C4B	2.91e-05	2	188	2	25339671
Pubmed	A study of association of the complement C4 mutations with systemic lupus erythematosus in the Malaysian population.	C4A C4B	2.91e-05	2	188	2	17728371
Pubmed	Structure and organization of the C4 genes.	C4A C4B	2.91e-05	2	188	2	6149580
Pubmed	Sequence heterogeneity of murine complementary DNA clones related to the C4 and C4-Slp isoforms of the fourth complement component.	C4A C4B	2.91e-05	2	188	2	6149581
Pubmed	Somatic mutations of the CDC4 (FBXW7) gene in hereditary colorectal tumors.	CDC40 FBXW7	2.91e-05	2	188	2	19420964
Pubmed	The follicular dendritic cell restricted epitope, FDC-M2, is complement C4; localization of immune complexes in mouse tissues.	C4A C4B	2.91e-05	2	188	2	12115608
Pubmed	Biochemistry and biology of anaphylatoxins.	C4A C4B	2.91e-05	2	188	2	3542363
Pubmed	C4 from C4-high and C4-low mouse strains have identical sequences in the region corresponding to the isotype-specific segment of human C4.	C4A C4B	2.91e-05	2	188	2	2387317
Pubmed	Identification of the size and antigenic determinants of the human C4 gene by a polymerase chain-reaction-based amplification method.	C4A C4B	2.91e-05	2	188	2	16908004
Pubmed	Structural studies on the murine fourth component of complement (C4). IV. Demonstration that C4 and Slp are encoded by separate loci.	C4A C4B	2.91e-05	2	188	2	7365238
Pubmed	Interaction between the labile binding sites of the fourth (C4) and fifth (C5) human complement proteins and erythrocyte cell membranes.	C4A C4B	2.91e-05	2	188	2	7391573
Pubmed	Peritubular capillary C4d deposition in lupus nephritis different from antibody-mediated renal rejection.	C4A C4B	2.91e-05	2	188	2	17971360
Pubmed	Clinical features of patients with homozygous complement C4A or C4B deficiency.	C4A C4B	2.91e-05	2	188	2	29928053
Pubmed	Analysis of C4 and the C4 binding protein in the MRL/lpr mouse.	C4A C4B	2.91e-05	2	188	2	17971229
Pubmed	Genetic deficiency of C4 presenting with recurrent infections and a SLE-like disease. Genetic and immunologic studies.	C4A C4B	2.91e-05	2	188	2	6881182
Pubmed	LATS1 but not LATS2 represses autophagy by a kinase-independent scaffold function.	LATS1 LATS2	2.91e-05	2	188	2	31848340
Pubmed	Competition between α-actinin and Ca²⁺-calmodulin controls surface retention of the L-type Ca²⁺ channel Ca(V)1.2.	ACTN1 ACTN2	2.91e-05	2	188	2	23664615
Pubmed	Expression of LATS family proteins in ovarian tumors and its significance.	LATS1 LATS2	2.91e-05	2	188	2	25841306
Pubmed	Partial C4 deficiency in juvenile idiopathic arthritis patients.	C4A C4B	2.91e-05	2	188	2	17921792
Pubmed	Complement activation and complement receptors on follicular dendritic cells are critical for the function of a targeted adjuvant.	C4A C4B	2.91e-05	2	188	2	21880985
Pubmed	Amino acid sequence around the thiol and reactive acyl groups of human complement component C4.	C4A C4B	2.91e-05	2	188	2	6978711
Pubmed	Plasma Complement 3 and Complement 4 Are Promising Biomarkers for Distinguishing NMOSD From MOGAD and Are Associated With the Blood-Brain-Barrier Disruption in NMOSD.	C4A C4B	2.91e-05	2	188	2	35898513
Pubmed	Borrelia burgdorferi outer surface protein C (OspC) binds complement component C4b and confers bloodstream survival.	C4A C4B	2.91e-05	2	188	2	28873507
Pubmed	Studies on the murine Ss protein: demonstration that the Ss protein is functionally the fourth component of complement.	C4A C4B	2.91e-05	2	188	2	276882
Pubmed	Amino acid sequence of a polymorphic segment from fragment C4d of human complement component C4.	C4A C4B	2.91e-05	2	188	2	6832377
Pubmed	The Drosophila developmental gene fat facets has a human homologue in Xp11.4 which escapes X-inactivation and has related sequences on Yq11.2.	USP9X USP9Y	2.91e-05	2	188	2	8922996
Pubmed	Recombination of two homologous MHC class III genes of the mouse (C4 and Slp) that accounts for the loss of testosterone dependence of sex-limited protein expression.	C4A C4B	2.91e-05	2	188	2	3794341
Pubmed	Evidence for a tumor suppressor role for the large tumor suppressor genes LATS1 and LATS2 in human cancer.	LATS1 LATS2	2.91e-05	2	188	2	24026096
Pubmed	Fine-tuned characterization of RCCX copy number variants and their relationship with extended MHC haplotypes.	C4A C4B	2.91e-05	2	188	2	22785613
Pubmed	Association between complement 4 copy number variation and systemic lupus erythematosus: a meta-analysis.	C4A C4B	2.91e-05	2	188	2	32691186
Pubmed	The androgen-dependent C4-Slp gene is driven by a constitutively competent promoter.	C4A C4B	2.91e-05	2	188	2	8390682
Pubmed	Structure and expression of murine fourth complement component (C4) and sex-limited protein (Slp).	C4A C4B	2.91e-05	2	188	2	3902619
Pubmed	Structural polymorphism of murine C4 and its linkage to H-2.	C4A C4B	2.91e-05	2	188	2	7373044
Pubmed	The chemical structure of the C4d fragment of the human complement component C4.	C4A C4B	2.91e-05	2	188	2	3696167
Pubmed	Restriction fragment length polymorphism of the murine C4 and Slp genes: two C4 groups.	C4A C4B	2.91e-05	2	188	2	1357031
Pubmed	Association analysis between SNPs in LATS1 and LATS2 and non-cardia gastric cancer.	LATS1 LATS2	2.91e-05	2	188	2	32423384
Pubmed	Deletion of Lats1/2 in adult kidney epithelia leads to renal cell carcinoma.	LATS1 LATS2	2.91e-05	2	188	2	34060480
Pubmed	Structural comparison of human C4A3 and C4B1 after proteolytic activation by C1s.	C4A C4B	2.91e-05	2	188	2	16098595
Pubmed	Increased frequency of C4B*Q0 alleles in patients with Henoch-Schönlein purpura.	C4A C4B	2.91e-05	2	188	2	15787745
Pubmed	Neuropil contraction in relation to Complement C4 gene copy numbers in independent cohorts of adolescent-onset and young adult-onset schizophrenia patients-a pilot study.	C4A C4B	2.91e-05	2	188	2	30026462
Pubmed	A molecular map of the human major histocompatibility complex class III region linking complement genes C4, C2 and factor B.	C4A C4B	2.91e-05	2	188	2	6559257
Pubmed	Promoter hypermethylation-mediated down-regulation of LATS1 and LATS2 in human astrocytoma.	LATS1 LATS2	2.91e-05	2	188	2	17049657
Pubmed	Genomic organization of the 70-kDa peroxisomal membrane protein gene (PXMP1).	ABCD3 ABCD4	2.91e-05	2	188	2	9521874
Pubmed	Complement C4 Is Reduced in iPSC-Derived Astrocytes of Autism Spectrum Disorder Subjects.	C4A C4B	2.91e-05	2	188	2	34299197
Pubmed	Assessment of complement C4 gene copy number using the paralog ratio test.	C4A C4B	2.91e-05	2	188	2	20506482
Pubmed	Polymerase chain reaction based C4AQ0 and C4BQ0 genotyping: association with systemic lupus erythematosus in southwest Han Chinese.	C4A C4B	2.91e-05	2	188	2	12480675
Pubmed	Low C4, C4A and C4B gene copy numbers are stronger risk factors for juvenile-onset than for adult-onset systemic lupus erythematosus.	C4A C4B	2.91e-05	2	188	2	26800705
Pubmed	Murine complement C4 is not required for experimental autoimmune encephalomyelitis.	C4A C4B	2.91e-05	2	188	2	15390104
Pubmed	Cloning and mapping of murine Dgcr2 and its homology to the Sez-12 seizure-related protein.	DGCR2 HIRA	2.91e-05	2	188	2	9107688
Pubmed	Lats1 and Lats2 are required for ovarian granulosa cell fate maintenance.	LATS1 LATS2	2.91e-05	2	188	2	31268774
Interaction	TOP3B interactions	TANC2 DGCR2 SPHK2 CRYBG2 CAD KALRN MYCBP2 TMC6 INTS1 OBSCN TRMT11 ACTN1 CFAP43 MED13L KLF4 THOC2 REPIN1 ADCY7 TBC1D9 KCNH3 HIRA DIP2A LATS2 PSME4 SUGP2 MTMR14 ZNRF3 GLI1 KCNK5 PCNX1 ZFYVE26 TANC1 POFUT1 SLC45A1 LRBA MAPKBP1	1.82e-08	1470	178	36	int:TOP3B
GeneFamily	WD repeat domain containing	DCAF8 COPB2 WDR27 CFAP43 SEC31B HIRA PLAA CDC40 NUP37 IFT80 LRBA MAPKBP1 SPAG16 WDR17 WDR62 FBXW7	5.80e-10	262	150	16	362
GeneFamily	Zinc fingers C2H2-type\|ZF class homeoboxes and pseudogenes	SCRT2 ZNF266 ZBTB48 ZFP57 ZNF225 ZNF112 KLF4 REPIN1 ZNF331 ZNF7 ZNF17 PRDM9 ZNF26 ZNF550 GLI1 ZNF358 ZNF620 ZNF747 ZNF749 ZNF841 ZNF443	5.11e-07	718	150	21	28
GeneFamily	Actinins	ACTN1 ACTN2	4.06e-04	4	150	2	1112
GeneFamily	ATP binding cassette subfamily D	ABCD3 ABCD4	4.06e-04	4	150	2	808
GeneFamily	T cell receptor beta locus at 7q34	TRBV7-8 TRBV7-7 TRBV7-6 TRBV7-4 TRBV7-2	7.86e-04	87	150	5	372
GeneFamily	Solute carriers	SLC12A5 SLC6A7 SLC25A32 SLC30A5 SLC20A2 SLC45A1 SLC23A1 SLC39A5 SLC25A23 SLC16A10	1.72e-03	395	150	10	752
GeneFamily	C3 and PZP like, alpha-2-macroglobulin domain containing	C4A C4B	2.37e-03	9	150	2	1234
GeneFamily	Adenylate cyclases\|Deafness associated genes	ADCY7 ADCY8	2.95e-03	10	150	2	53
GeneFamily	Complement system\|Sushi domain containing	CR2 C4A C4B	3.27e-03	36	150	3	492
ToppCell	droplet-Lung-30m-Hematologic-myeloid-interstitial_macrophage\|30m / method, tissue, age, lineage, sublineage, cell ontologies, cell type and subtype	TANC2 CTSC RENBP PLD3 LIPA CD5L C4B ADGRE1	8.95e-07	178	187	8	c85de851b39cb8ef7ea1866ab64c6a387788273a
ToppCell	droplet-Lung-30m-Hematologic-myeloid-interstitial_macrophage-interstitial_macrophage_33\|30m / method, tissue, age, lineage, sublineage, cell ontologies, cell type and subtype	TANC2 CTSC RENBP PLD3 LIPA CD5L C4B ADGRE1	9.33e-07	179	187	8	13d80ae2e43a5daad0aeb5f47338efca2c58800a
ToppCell	nucseq\|World / Celltype signatures by Technology, Lineage, Lineage_subclass, Celltype_group, Cell_type2	TANC2 STAG1 MED13L CMIP PCNX1 LRBA KYNU SLC16A10	1.64e-06	193	187	8	779276e775cb2492e8dd36436295a536084a6415
ToppCell	droplet-Lung-3m-Mesenchymal-fibroblast-adventitial_fibroblast-adventitial_fibroblast_l49\|3m / method, tissue, age, lineage, sublineage, cell ontologies, cell type and subtype	PAMR1 OBSCN F8 SLC12A5 SLC6A7 C4A C4B	7.20e-06	168	187	7	d2b91f2adc95dcfa623f8d7ca2df1c6f884da988
ToppCell	5'-Adult-Appendix-Mesenchymal-myocytic-myofibroblast\|Adult / Celltypes from developing, pediatric, Crohn's, & adult GI tract	MAP1B FAXC GLI1 AOC3 SLC45A1 PLEKHH2 PTGDR2	1.01e-05	177	187	7	e65c0568dc5852108e9802273499bc7cf88fafab
ToppCell	facs-Spleen-nan-3m-Lymphocytic-CD8-positive,_alpha-beta_T_cell\|Spleen / Spleen_Marrow_Thymus - method, tissue, subtissue, age, lineage, cell ontology and free annotation	ACTN1 ACTN2 PLD3 ZNRF3 LEPROTL1 TANC1 IFT80	1.01e-05	177	187	7	ac0cf03e2a1baf84db3ae245d59bbc6ae52c13be
ToppCell	facs-Thymus\|facs / Spleen_Marrow_Thymus - method, tissue, subtissue, age, lineage, cell ontology and free annotation	CPA1 PLD3 KCNH3 LIPA ZNRF3 SYTL3 LEPROTL1	1.30e-05	184	187	7	58beef66bbbde2479ec69dfef392d5941cedf230
ToppCell	Control-Myeloid-Macrophage_Alveolar\|World / Disease state, Lineage and Cell class	TANC2 CTSC PLD3 CD5L PSME4 AOC3 ADIPOR2	1.35e-05	185	187	7	85cb81759589a26d83676cffbf2bc37399683c10
ToppCell	10x_3'_v3-thymus_(10x_3'_v3)-lymphocytic-T_lymphocytic_-_developing-thymocyte\|thymus_(10x_3'_v3) / Per Platform+tissue_group, by lineage_subgroup, cell_group, cell_type	ACTN1 ANKRD55 TXNIP SYTL3 DPPA4 ABCD3 IFT80	1.50e-05	188	187	7	bcfc426b60d8e5a23a2360bfb68b32868fec9fbf
ToppCell	Control-Myeloid-Macrophage_Alveolar\|Myeloid / Disease state, Lineage and Cell class	TANC2 CTSC TXNIP CD5L PSME4 AOC3 ADIPOR2	1.66e-05	191	187	7	a7bb8aba9c59c037d995a77928cc7b4d5cbb82b9
ToppCell	(4)_Endothelial_cells-(42)_EC-sinusoidal\|(4)_Endothelial_cells / Cell class and subclass of bone marrow stroma cells in homeostatis	GALNT15 MAP1B CTSC ACTN1 F8 TXNIP BOK	1.83e-05	194	187	7	4199900d16623eca02d674d5ada7f0989e47955e
ToppCell	10x5'v1-week_14-16-Myeloid_macrophage\|week_14-16 / cell types per 3 fetal stages;per 3',per 5'	CTSC ACTN2 PLD3 SLC12A5 LIPA CD5L SLC16A10	1.96e-05	196	187	7	e0447ad2efb021b63c7fef000d39b6b21fbe6113
ToppCell	10x5'v1-week_14-16-Myeloid_macrophage-stroma\|week_14-16 / cell types per 3 fetal stages;per 3',per 5'	CTSC ACTN2 PLD3 SLC12A5 LIPA CD5L SLC16A10	1.96e-05	196	187	7	3bca88eede3dd7368715ced02e3bacd1e3e82cab
ToppCell	10x_3'_v2v3-Non-neoplastic-Myeloid-Mono-Mono_anti-infl-F\|10x_3'_v2v3 / Platform, Oncotype, Lineage, Cell_class, celltype (level4), mutation group	CTSC RENBP PLD3 TDP2 TXNIP LIPA SLC16A10	2.23e-05	200	187	7	2cca77b2c9d829daa674a844e068f2b083e90d6e
ToppCell	10x5'v1-week_14-16-Myeloid_macrophage-stroma-stromal_macrophage\|week_14-16 / cell types per 3 fetal stages;per 3',per 5'	CTSC PLD3 TBC1D9 SLC12A5 LIPA CD5L SLC16A10	2.23e-05	200	187	7	af743dfef7e7cfaef1c494999757123f93a213e3
Drug	d 1b	PLD3 ADCY7 ADCY8 LATS1 LATS2 DROSHA GLI1	6.31e-07	62	182	7	CID000449090
Drug	AC1MRBNS	DGCR2 F8 DROSHA C4A LRBA TAFAZZIN	4.51e-06	54	182	6	CID003465634
Drug	BAS 012416453; Down 200; 38uM; MCF7; HT_HG-U133A	DGCR2 HDAC5 ZBTB48 DDX52 SOWAHC PIGQ TXNIP SLC25A23 WDR62 TRMT61A	4.61e-06	198	182	10	6908_DN
Disease	Neoplasms, Glandular and Epithelial	AS3MT LATS1	3.50e-05	2	175	2	C0027660
Disease	Epithelioma	AS3MT LATS1	3.50e-05	2	175	2	C1368683
Disease	Glandular Neoplasms	AS3MT LATS1	3.50e-05	2	175	2	C0205854
Disease	primary autosomal recessive microcephaly 2 with or without cortical malformations (implicated_via_orthology)	MAPKBP1 WDR62	3.50e-05	2	175	2	DOID:0070293 (implicated_via_orthology)
Disease	focal segmental glomerulosclerosis 1 (implicated_via_orthology)	ACTN1 ACTN2	3.46e-04	5	175	2	DOID:0111128 (implicated_via_orthology)
Disease	brain disease (implicated_via_orthology)	MYCBP2 DROSHA	5.16e-04	6	175	2	DOID:936 (implicated_via_orthology)
Disease	Hereditary pancreatitis	CTRC CPA1	7.20e-04	7	175	2	C0238339
Disease	microcephaly (implicated_via_orthology)	COPB2 MAPKBP1 WDR62	8.96e-04	32	175	3	DOID:10907 (implicated_via_orthology)
Disease	helix rolling	SOWAHC LRBA	9.57e-04	8	175	2	EFO_0007670
Disease	CMRF35-like molecule 6 measurement	FAM30A GALNT4	9.57e-04	8	175	2	EFO_0008086
Disease	benign neoplasm (implicated_via_orthology)	LATS1 LATS2	9.57e-04	8	175	2	DOID:0060072 (implicated_via_orthology)
Disease	Pancreatitis, Chronic	CTRC CPA1	1.23e-03	9	175	2	C0149521
Disease	post-traumatic stress disorder	CTSC ACTN1 ANKRD55 ADCY8 ZNF331 IFT80	1.34e-03	202	175	6	EFO_0001358
Disease	reticulocyte count	SPHK2 USP9X TMC6 ZFP57 ACTN1 ACVR1C ANKRD55 ADCY8 SLC12A5 PIGQ P2RY2 C4B SLC45A1 SLC23A1 HCRTR1	1.47e-03	1045	175	15	EFO_0007986
Disease	clinical treatment	MYCBP2 CTSC ADCY7	1.85e-03	41	175	3	EFO_0007056
Disease	kidney cancer (implicated_via_orthology)	LATS1 LATS2	1.86e-03	11	175	2	DOID:263 (implicated_via_orthology)
Disease	phenylacetate measurement	KLF4 ACSM2B	2.22e-03	12	175	2	EFO_0021012
Disease	Common variable immunodeficiency	CR2 LRBA	2.61e-03	13	175	2	cv:C0009447
Disease	Respiratory Depression	IFT80 SLC23A1	2.61e-03	13	175	2	C0235063
Disease	Respiratory Insufficiency	IFT80 SLC23A1	2.61e-03	13	175	2	C0035229
Disease	Respiratory Failure	IFT80 SLC23A1	2.61e-03	13	175	2	C1145670
Disease	Asthma, Aspirin-Induced	CYSLTR1 PTGDR2	2.61e-03	13	175	2	C1319853
Disease	hepatocellular carcinoma (implicated_via_orthology)	CAD TXNIP ING4	3.09e-03	49	175	3	DOID:684 (implicated_via_orthology)
Disease	Disease Exacerbation	CTSC KLK3 ABCC6 TXNIP ABCD4	3.10e-03	165	175	5	C0235874
Disease	Colorectal Carcinoma	CAD MAP1B KALRN OBSCN ABCC6 ADCY8 SLC12A5 ABCD3 ABCD4 ING4 FBXW7	3.26e-03	702	175	11	C0009402
Disease	DiGeorge Syndrome	DGCR2 HIRA	3.97e-03	16	175	2	C0012236
Disease	CONOTRUNCAL ANOMALY FACE SYNDROME	DGCR2 HIRA	3.97e-03	16	175	2	C0795907
Disease	primary autosomal recessive microcephaly (is_implicated_in)	NUP37 WDR62	3.97e-03	16	175	2	DOID:0070296 (is_implicated_in)
Disease	Shprintzen syndrome	DGCR2 HIRA	3.97e-03	16	175	2	C0220704
Disease	thyroxine measurement, triiodothyronine measurement	GALNT15 ZNF841	4.49e-03	17	175	2	EFO_0005130, EFO_0008392
Disease	non-alcoholic steatohepatitis (biomarker_via_orthology)	NOX4 ADIPOR2	4.49e-03	17	175	2	DOID:0080547 (biomarker_via_orthology)

Protein segments in the cluster

Peptide	Gene	Start	Entry
HSGSVLCGVLGLRKW	ADCY8	511	P40145
HSFRAGKIWVLICTA	DDX52	456	Q9Y2R4
SEGWILIDRCGKHFG	KCTD10	71	Q9H3F6
GLIGKWHLGLSCASR	ARSH	111	Q5FYA8
LSSHGLWLITIAKCG	CFAP43	646	Q8NDM7
ISWKDGLGFCALIHR	ACTN1	171	P12814
FHTSWKDGLGLCALI	ACTN2	176	P35609
VFWACRGGHLVILKQ	ANKRD23	181	Q86SG2
VHYTVCIWRNGKVGL	C4B	1466	P0C0L5
RAALEACHKGWGVSV	ADH5	276	P11766
KHIFWSDSGELVCIA	COPB2	466	P35606
WRKTRSHTAGSLCIG	CPA1	236	P15085
HLCRGWAETLTKALA	GTPBP3	186	Q969Y2
HGRWCGEDVAVKIFS	ACVR1C	211	Q8NER5
VHSCLLSVRAGKDGW	CMIP	511	Q8IY22
SGVRWCVVHGKSLPA	DPPA4	226	Q7L190
NLCSGRLEVLHKGVW	CD5L	251	O43866
RLEVLHKGVWGSVCD	CD5L	256	O43866
WLEGCVSLLRNGAKH	ANKRD55	106	Q3KP44
HSLVLKLCGGGRWEL	ABCD4	586	O14678
HSGNVLCGVIGLRKW	ADCY7	376	P51828
KCVVSTDPGLRSHWL	BOK	176	Q9UMX3
GKDLVAWVTAGFLHI	AOC3	671	Q16853
CEAAHFGLWRICTKR	CACNG1	46	Q06432
TGNIWTHLLGCVFFL	ADIPOR2	146	Q86V24
ITIALIGTGWAFIKH	GPR107	346	Q5VW38
ILLHCGALRATWDGF	KCNH3	216	Q9ULD8
LHCLTTIWKLDGLRG	SLC25A32	66	Q9H2D1
LGVWVTLKGSAHVCL	ARHGEF17	1871	Q96PE2
FSNLLRWVVCHITKG	FAXC	226	Q5TGI0
EAGWFLLRHCIRKGD	RENBP	261	P51606
RGVKVRLLISCWGHS	PLD3	356	Q8IV08
HSLCILLVAVAWVGG	OR4C12	136	Q96R67
GRWKALSTCGSHIAV	OR4C15	231	Q8NGM1
GCGWKFARSDELTRH	KLF4	466	O43474
TTPLVWAARKGHLEC	KIDINS220	171	Q9ULH0
GGSERKSCFWKLIRH	MAP1B	286	P46821
HGELKDWSILLGECS	MED13L	1906	Q71F56
VYLGHGLDTCGWKIL	JMY	291	Q8N9B5
GERIWVDSPHCKTFV	INTS1	236	Q8N201
HIKLTDFGLCTGFRW	LATS1	841	O95835
KLTDFGLCTGFRWTH	LATS2	806	Q9NRM7
RLWHSGRCDLFQEKG	MST1L	96	Q2TV78
FKGKHICRSATLAGW	MTMR14	136	Q8NCE2
NRLCTLASLKAVWHG	DIO3	106	P55073
LSFKAWLCGGSVEIL	GALNT15	396	Q8N3T1
IVSTWHRLRKGCGAG	PCNX1	2026	Q96RV3
CLTWISALGKFFGGR	KCNK5	126	O95279
DICAFIEKHWTFLLG	KAT14	151	Q9H8E8
VSGSDCGHIFLWEKS	DCAF8	451	Q5TAQ9
HVEGDPCKFALWSGR	KALRN	1536	O60229
VTGLELAHCSGLWAF	NOTO	126	A8MTQ0
AHLIEWGACALVLTG	LEPROTL1	91	O95214
TEGLHGKWLFTEIRS	LRBA	2126	P50851
KEFVCHWGGCSRELR	GLI1	266	P08151
KAGIWRVECLIGEHL	F8	2011	P00451
LALSHCSRLSDKGWA	LRRC29	131	Q8WV35
CVIGGDHKLLFWVTE	NUP37	311	Q8NFH4
TRGKWKAFSTCGLHL	OR1I1	231	O60431
PKLLAIFWCGAGHIS	OR52P1	81	Q8NH57
GDHWPFSTVLCKLVR	P2RY2	96	P41231
LAVGHSWELGTTFCK	PTGDR2	91	Q9Y5Y4
HCFTESGRGKSWRLC	PLPP4	166	Q5VZY2
VKHGYSKRVWCTLIG	PLEKHH2	821	Q8IVE3
RSWLANEGVKHLCLF	NOX4	6	Q9NPH5
GSHLTVVSLWFGACI	OR2AE1	241	Q8NHA4
VKEGATGQWRLCHEL	OBSCN	4561	Q5VST9
ECGRGFSWKSHLLIH	PRDM9	556	Q9NQV7
TVFEKHWCDTSIGGL	IL1RL2	111	Q9HB29
CLGIGAAFEKWGTLH	ITPRIPL1	216	Q6GPH6
GTLDECLTHFLEWGK	PRAMEF12	156	O95522
VDITESWLFGHALCK	HCRTR1	106	O43613
DAWLFGALVCKAVHL	GALR3	86	O60755
VGSFHTLRLCDKTGW	IFT80	246	Q9P2H3
KNDTWRHTCGGTLIA	CTRC	51	Q99895
LVGEALLLCTHEGTW	CR2	886	P20023
LSFRVWQCGGKLEIH	GALNT4	341	Q8N4A0
FSSRLTHFIWKICGQ	FMO5	236	P49326
IKGGIWVLCEHSDFR	CRYBG2	1481	Q8N1P7
WSAVTGKCLRTLVGH	FBXW7	406	Q969H0
VHDVLGRNWACFTGK	CTSC	126	P53634
IRTHKVLWGECLGGA	AS3MT	196	Q9HBK9
VRFSSFLGKCPTGWH	DGCR2	106	P98153
GLGYSKCILVAHDWG	EPHX3	161	Q9H6B9
KHLISVSGDSCIFVW	MAPKBP1	716	O60336
SKSGICSLHPLLRGW	HEATR1	626	Q9H583
DFKRDAGLWHGVLTS	DIP2A	556	Q14689
KHWSCVQKFAAGLGR	HDAC5	1056	Q9UQL6
FDECGGTTHVLRLSW	HIRA	216	P54198
LLGHRICTDIGKGWR	FAM30A	66	Q9NZY2
HCKVGSVVAVGWIRS	SLC20A2	596	Q08357
GNHKWGLLLTVCGVV	SLC45A1	221	Q9Y2W3
LARECGLWLSLGGFH	NIT1	116	Q86X76
GWLCIEKFSGEVHTA	CDH16	606	O75309
VHYTVCIWRNGKVGL	C4A	1466	P0C0L4
WFHFACVGLTTKPRG	ING4	221	Q9UNL4
AVAWALKHFSRCIGD	NYNRIN	1211	Q9P2P1
HKGAWFLVCSGALVN	PAMR1	481	Q6UXH9
TLSRHGFDVCAKLAW	SLC12A5	316	Q9H2X9
GIHLRIGSDWKNACA	POFUT1	236	Q9H488
DRIRHWIGCGAHLSK	MRPS16	71	Q9Y3D3
CRVFLRGTHAWKCTV	SYTL3	91	Q4VX76
AVSGWKFEIHRCIIN	USP9X	136	Q93008
GFWKTGIRSDVCQHA	DROSHA	846	Q9NRR4
RTVCAKSIFELWGHG	TRMT11	66	Q7Z4G4
VCGKAFSRPWLLQGH	SCRT2	216	Q9NQ03
CSLSVHIDKGFTLWA	SNTA1	421	Q13424
CLSLLREHSIDGTGW	UBE2F	116	Q969M7
LKSCHTGLRRTAGWN	LTF	131	P02788
IKFHGWEGAFLDRVL	ABCC6	501	O95255
PRHGELWCAVSKDIA	PRPF6	906	O94906
HTWCKGIVGDLRPTA	TDRD12	271	Q587J7
AWLTGEHGCVRLIFQ	PELI3	451	Q8N2H9
WHVGLSACLGLTVAL	PIGQ	371	Q9BRB3
HETSKVITCGWDGLI	CDC40	561	O60508
ALSWACLKGHRAVVQ	TANC1	1181	Q9C0D5
ALSWACLKGHLSVVR	TANC2	1136	Q9HCD6
KVDLHEGCGRTKLFW	MYCBP2	4311	O75592
HVKWSPLREGILCSG	WDR17	571	Q8IZU2
KRDFITGFTCLHWAA	SOWAHC	296	Q53LP3
GVLSALSRFHKLVWG	SEC31B	61	Q9NQW1
HRGNWTGKLDFLLSC	SLC6A7	36	Q99884
CGQSFRGWVALVLHL	REPIN1	121	Q9BWE0
VSHLLAGFCVWVVLG	SLC39A5	6	Q6ZMH5
GCGKSSLFRVLGELW	ABCD3	476	P28288
DVKGGRWTSFGCVIL	ADGRE1	556	Q14246
SWTLGACTFVHLLPK	ACSM2B	276	Q68CK6
GHIKVLVCTATLAWG	ASCC3	801	Q8N3C0
SRGFLLCKTGWHSNR	COA6	11	Q5JTJ3
KGIWLFGDFLCRLST	CYSLTR1	86	Q9Y271
RLWKLVGATSFGIGC	TMPRSS3	411	P57727
DVGGLVFKAHWSVLA	ZBTB48	31	P10074
ADVHGIWSRLFCDFG	UBA6	186	A0AVT1
HCWLVGKNRTTIESF	ZDHHC20	231	Q5W0Z9
FALLSSVGCWHGAKD	ZNF749	41	O43361
WEKSGRGEFLHLCRI	THOC2	16	Q8NI27
CRVILGQWLGFSHDV	ZFP57	391	Q9NU63
LFLGTADGWIHKAVV	SEMA4G	446	Q9NTN9
FDDGLVHLCWVRSGI	SPHK2	561	Q9NRA0
RFKWGIGRLIAECHL	TAFAZZIN	161	Q16635
RAGSHWGISACSILL	SLC23A1	206	Q9UHI7
WLALIERGGCTFTHK	RNF148	101	Q8N7C7
ALGKDWCLRVGKFLH	SPDYC	136	Q5MJ68
FHEFCIRGWCIVGKK	RNF175	256	Q8N4F7
SLKHCEFWLERGAGL	PRND	141	Q9UKY0
CGKSFAWRSTLVEHI	ZNF747	186	Q9BV97
VLLTGFGHTDWLSDC	SPAG16	386	Q8N0X2
HAWDALKVEGGRFCS	TRMT61A	191	Q96FX7
SRFGIEIIKWAGFHT	SUGP2	326	Q8IX01
WTIACGGSRKEITEH	TBC1D9	76	Q6ZT07
KLWKAGRCERTFSGH	PLAA	176	Q9Y263
VCGKTFSWCGRFILH	ZNF620	396	Q6ZNG0
KLDCGRFPSDHWGLL	TDP2	341	O95551
DCGKAFRWGSSLVIH	ZNF331	191	Q9NQX6
ECGKAFRWGSSLVKH	ZNF331	331	Q9NQX6
REHGCGKSTLIANWV	TTC41P	341	Q6P2S7
GWTLHDRQGEVRLKC	STAG1	336	Q8WVM7
LCWVVLGFLGTDHTG	TRBV7-6	6	A0A1B0GX31
LCWVVLGFLGTDHTG	TRBV7-7	6	A0A0K0K1E9
EAVSGWKFEIHRCII	USP9Y	136	O00507
EIIAGLIRGSKHWTF	PSME4	1381	Q14997
GSRCKNRTGAEHLWL	MRM2	21	Q9UI43
GLCKWFESSGIHVAA	CAD	71	P27708
ECGKSFRWASGLSRH	ZNF225	376	Q9UK10
ITVSGDSCVFIWHLG	WDR62	731	O43379
ECGKAFNWGSLLTVH	ZNF841	401	Q6ZN19
CGKGFRWSSGLLIHQ	ZNF112	866	Q9UJU3
WIVKRGLSHATCAGD	ZNF550	71	Q7Z398
GKAFSWLTCFLRHER	ZNF443	566	Q9Y2A4
FKHAVAGCIISLLWF	SLC30A5	96	Q8TAD4
GKSFCWNSGLRIHRK	ZNF26	516	P17031
DLRRTWKGGHELPSC	ZNRF3	696	Q9ULT6
FWKHSTVLDIGECLT	SLC25A23	156	Q9BV35
LKLAILGTLCYHWLG	TMC6	516	Q7Z403
LGTLCYHWLGRRVGV	TMC6	521	Q7Z403
LIGSHSGVKLCRWTK	TYW1	371	Q9NV66
DRGFKVWDHCTGSLI	WDR27	186	A2RRH5
LFWVAFCLLGADHTG	TRBV7-2	6	A0A1B0GXF2
HIISGTCASWRGKSL	TXNIP	241	Q9H3M7
LLGWTHCQSLESAKR	ZFYVE26	371	Q68DK2
LCWVVLGFLGTDHTG	TRBV7-8	6	A0A1B0GX51
FALLSSVGCWHGAKD	ZNF17	41	P17021
SVITGGCIIFLHWRK	TEX38	26	Q6PEX7
LCWVVLGFLGTDHTG	TRBV7-4	6	A0A1B0GX95
CGKGIRATSDIALHW	ZNF7	201	P17097
ACGKAFGWRSTLLKH	ZNF358	211	Q9NW07
QTWSFREGKLTCGLH	VPS13D	3711	Q5THJ4
WKECGRGFIHSTDLA	ZNF266	186	Q14584
IGGAVLCFIPWIHSK	SLC16A10	461	Q8TF71
ILSRIVGGWECEKHS	KLK3	21	P07288
ALVGWFGHELSTRFK	KYNU	301	Q16719
CLVLWTLHSEGSGGK	LIPA	11	P38571